Showing 241-250 of 8777 results for "".
Addressing the Unique Challenges of AD Patients
https://practicaldermatology.com/series/c-suite-chats/addressing-the-unique-challenges-of-ad-patients/28617/Patrick Burnett, MD, PhD, Chief Medical Officer at Arcutis Bioteheraputics, discusses the promise of the company’s roflumilast cream for AD.Long Shot: Daxxify Shows Promise
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/long-shot-daxxify-shows-promise/23819/Charles Boyd, MD and Marina Peredo, MD highlight the Daxxify difference.How to Ensure ‘People-First’ Content
https://practicaldermatology.com/issues/january-february-2025/how-to-ensure-people-first-content/32978/As members of the medical community, we have a strong sense of purpose and ethical responsibility to our patients and communities.How to Recognize Physician Burnout
https://practicaldermatology.com/series/pa-perspectives/how-recognize-physician-burnout/29206/In this video, Andrew Mastro, MS, PA-C, a board-certified physician assistant (PA) at the Illinois Dermatology Institute in Chicago, discusses how to recognize physician burnout, and the importance of strategically adding breaks in your monthly schedule.Pigmentation: Melasma vs. Postinflammatory Hyperpigmentation
https://practicaldermatology.com/conferences/maui-derm-2024/pigmentation-melasma-vs-hyperpigmentation-vitiligo-treatments-and-full-spectrum-photo-protection/20247/Chief Medical Editor Neal Bhatia, MD and Pearl Grimes, MD, discuss Dr. Grimes’ presentations on pigmentation, including the difference between melasma and postinflammatory hyperpigmentation, and the importance of photo-protection in darker skin types.Exciting Developments in Treating Pediatric Dermatology
https://practicaldermatology.com/conferences/maui-derm-2024/exciting-developments-in-treating-pediatric-dermatology/20246/Chief Medical Editor Neal Bhatia, MD and Lawrence Eichenfield, MD, discuss the range of therapies currently approved or in the pipeline for atopic dermatitis, pruritus, pediatric acne--and the importance of messaging on TikTok.Preventing AD in High-Risk Infants
https://practicaldermatology.com/topics/atopic-dermatitis/preventing-ad-in-high-risk-infants/20223/Early initiation of short-term emollient use, especially one that contains colloidal oatmeal, can improve skin barrier function and slash the chances of developing atopic dermatitis in high-risk infants. Paul Horowitz, MD, a pediatrician in Valencia, CA, shares highlights from his talk on the STOP-A5 Year Plan: Innovation Update
https://practicaldermatology.com/conferences/asds-2021/5-year-plan-innovation-update/20024/Mat Avram, MD provides an update on newly approved technologies as well as some that could be in use in practice within the next five years to improve outcomes or increase safety.Managing Skin Disease in Cancer Patients
https://practicaldermatology.com/topics/skin-cancer-photoprotection/managing-skin-disease-in-cancer-patients/19927/Skin reactions to cancer therapeutics can lead to difficult-to-manage rashes. Biologics can present an effective, appropriate option, but dermatologists need to know which biologics to select and when. Anisha Patel, MD provides an overview.Hidradenitis Suppurativa: A Prevalent "Rare" Disease
https://practicaldermatology.com/topics/rare-disease/hidradenitis-suppurativa-a-prevalent-rare-disease/19926/Beyond recognizing that hidradenitis suppurativa is far more prevalent than once believed, research has also elucidated disease mechanisms, comorbidities, and pain pathways. Haley Naik, MD provides important updates on this previously neglected disease.